Costs of cancer along the care continuum: what we can expect based on recent literature

M Pisu, NB Henrikson, MP Banegas, KR Yabroff - Cancer, 2018 - Wiley Online Library
Background Cancer costs should be discussed by patients and providers, but information is
not readily available. Results from recently published studies (in the last 5 years) on direct …

The estimated direct lifetime medical costs of sexually transmitted infections acquired in the United States in 2018

HW Chesson, IH Spicknall, A Bingham… - Sexually transmitted …, 2021 - journals.lww.com
Background We estimated the lifetime medical costs attributable to sexually transmitted
infections (STIs) acquired in 2018, including sexually acquired human immunodeficiency …

Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States

HW Chesson, E Meites, DU Ekwueme… - Human vaccines & …, 2019 - Taylor & Francis
Estimates of medical care costs for cervical and other cancers associated with human
papillomavirus (HPV) are higher in studies published in recent years than in studies …

Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States

JF Laprise, HW Chesson, LE Markowitz… - Annals of internal …, 2020 - acpjournals.org
Background: In the United States, the routine age for human papillomavirus (HPV)
vaccination is 11 to 12 years, with catch-up vaccination through age 26 years for women and …

An insight into synthesis and antitumor activity of citrate and gallate stabilizing gold nanospheres

MM Fathy, AA Elfiky, YS Bashandy, MM Hamdy… - Scientific Reports, 2023 - nature.com
Both gallic and citrate are well-established antioxidants that show promise as new selective
anti-cancer drugs. Gold nanoparticles (AuNPs) as well can be developed as flexible and …

The estimated lifetime medical cost of diseases attributable to human papillomavirus infections acquired in 2018

HW Chesson, JF Laprise, M Brisson… - Sexually transmitted …, 2021 - journals.lww.com
Methods We adapted an existing mathematical model of HPV transmission and associated
diseases to estimate the lifetime number of diagnosed cases of disease (genital warts; …

Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer

FB Musa, E Brouwer, J Ting, NRM Schwartz… - Gynecologic …, 2022 - Elsevier
Background Current treatments for recurrent or metastatic cervical cancer (r/mCC) do not
offer satisfactory clinical benefits, with most patients progressing beyond first-line (1L) …

Economic and humanistic burden of cervical cancer in the United States: results from a nationally representative survey

R Shah, C Nwankwo, Y Kwon… - Journal of women's …, 2020 - liebertpub.com
Objective: To measure the economic and humanistic burden of cervical cancer in the United
States. Materials and Methods: This was a retrospective analysis of Medical Expenditure …

Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model

HW Chesson, E Meites, DU Ekwueme, M Saraiya… - Vaccine, 2020 - Elsevier
Introduction The objective of this study was to assess incremental costs and benefits of a
human papillomavirus (HPV) vaccination program expanded to include “mid-adults”(adults …

Clinical and economic burden of HPV-related cancers in the US veteran population

K Saxena, RS Dawson, A Cyhaniuk… - Journal of Medical …, 2022 - Taylor & Francis
Background Human papillomavirus (HPV) is one of the most common sexually transmitted
infection in the United States and can lead to cervical, vulvovaginal, anal, penile, and …